Related Experiment Videos
The European Concerted Action NCL Clinical Case Registry
R E Williams1, R M Gardiner, H H Goebel
1Department of Paediatrics, UCLMS, The Rayne Institute, University Street, London, United Kingdom.
Insights
A European registry for neuronal ceroid lipofuscinosis (NCL) cases was established to facilitate research. This registry collects anonymized data on affected children for epidemiological, molecular, and diagnostic studies.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Neuronal ceroid lipofuscinosis (NCL) comprises a group of rare genetic disorders.
- Establishing comprehensive patient registries is crucial for understanding rare diseases.
Purpose of the Study:
- To establish a centralized European registry for NCL cases.
- To facilitate research into the epidemiology, molecular basis, diagnosis, and treatment of NCL.
Main Methods:
- A European NCL Clinical Case Registry was created in London.
- Anonymized clinical information from affected children was collected from Concerted Action participants.
- Data entry and management were established for the registry.
Main Results:
- The registry successfully collected data on 60 NCL cases by May 1998.
- Contributors could access registry data for research purposes.
Conclusions:
- The European NCL Clinical Case Registry provides a valuable resource for NCL research.
- The registry supports collaborative efforts in understanding and addressing NCL.
Abstract:
A European NCL Clinical Case Registry has been set up in London, as part of a European Union-funded Concerted Action project. Concerted Action participants provide written information about children which is then anonymized and entered on the Registry. Contributors are able to request information contained within the Registry for the purpose of epidemiological, molecular, diagnostic, or therapeutic research. Up to May 1998, 60 cases were entered on the Registry.